DTC
HRTX icon

Deep Track Capital’s Heron Therapeutics HRTX Stock Holding History

Deep Track Capital’s Portfolio HRTX Stock Details HRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-2,086,704
Closed -$2.15M – 68
2023
Q3 		$2.15M Hold
2,086,704
– – 0.08% 61
2023
Q2 		$2.42M Sell
2,086,704
-1,148,018
-35% -$2.05M 0.11% 51
2023
Q1 		$4.88M Sell
3,234,722
-3,262,254
-50% -$8.17M 0.2% 50
2022
Q4 		$16.2M Sell
6,496,976
-2,051,411
-24% -$6.61M 0.68% 42
2022
Q3 		$36.1M Buy
+8,548,387
New +$33.4M 1.65% 23

Other funds holding HRTX

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Deep Track Capital's HRTX Position: Q4 2023 in Review

Deep Track Capital sold out of Heron Therapeutics (HRTX) in Q4 2023, closing a stake of 2,086,704 shares — an estimated $2.15M sold.

Deep Track Capital first reported a position in HRTX in Q3 2022 and held it in 5 quarters. The position peaked at $36.1M in Q3 2022. 151 funds tracked by Wall St. Rank hold HRTX as of Q4 2023.

  • Deep Track Capital reported no remaining Heron Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Deep Track Capital sold 2,086,704 Heron Therapeutics shares in Q4 2023, an estimated $2.15M.
  • Deep Track Capital first reported a position in Heron Therapeutics in Q3 2022 and held it in 5 quarters.
  • Deep Track Capital's Heron Therapeutics position peaked at $36.1M in Q3 2022.
  • 151 funds tracked by Wall St. Rank held Heron Therapeutics as of Q4 2023.

Based on Deep Track Capital's 13F filing for Q4 2023, filed 14 Feb 2024.